Obstructive sleep apnoea: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• GLP-1 6
• SGLT2 0

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Post-Operative Steroids After Sleep Surgery

  NCT06818981· Medical University of South Carolina· Updated 6 Oct 2026

  “Lack of funding”Registry text, quoted unchanged. Source

• Withdrawn

  Impact of Exogenous Ketones on Sleep Apnea

  NCT06687655· Johns Hopkins University· Updated 21 Sept 2026

  “Change in protocol due to requirement for IND”Registry text, quoted unchanged. Source

• Withdrawn

  Prevalence Study and Identification of Factors Prognosis of Obstructive Sleep Apnea Syndrome Sleep in Pregnant Women

  NCT05725642· GCS Ramsay Santé pour l'Enseignement et la Recherche· Updated 20 Aug 2026

  “Feasibility issue”Registry text, quoted unchanged. Source

• Terminated

  Whole Food Plant-based Diet Effect on Obstructive Sleep Apnea

  NCT06395181· Mayo Clinic· Updated 22 Jul 2026

  “Lack of funding to continue.”Registry text, quoted unchanged. Source

• Withdrawn

  Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea (ARCTIC_AUS)

  NCT07021833· Cryosa, Inc.· Updated 13 Jul 2026

  “Sponsor decision. Study withdrawn prior to enrollment of first participant to prioritize initiation of the pivotal trial in the United States.”Registry text, quoted unchanged. Source

• Suspended

  Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations

  NCT06655649· Johns Hopkins University· Updated 23 Jun 2026

  “Funding changes, may resume later”Registry text, quoted unchanged. Source

• Suspended

  Obstructive Sleep Apnea and Glucose Metabolism

  NCT03408613· University of Missouri-Columbia· Updated 8 May 2026

  “equipment recall”Registry text, quoted unchanged. Source

• Withdrawn

  MEA DPA Hypoxic Event Reductions

  NCT07572500· Stanford University· Updated 7 May 2026

  “Unable to secure funding for the study.”Registry text, quoted unchanged. Source

• Terminated

  Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol

  NCT05255744· ResMed· Updated 27 Apr 2026

  “The study was discontinued prior to initiation because startup activities could not be completed within the planned timelines.”Registry text, quoted unchanged. Source

• Suspended

  Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea

  NCT04607343· Fundación Neumologica Colombiana· Updated 13 Apr 2026

  “Lack of resourses and regulatory agency approval”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Use of a Mandibular Advancement Appliance in Children With Obstructive Sleep Apnea

  NCT07902908· National Institute of Dental and Craniofacial Research (NIDCR)· Source

• Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

  NCT05656365· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER‑OSA 1)

  2026-526327-22-00· Pfizer Inc.· Source

• Supplemental Oxygen for Sleep-Disordered Breathing in Adults With Chronic Opioid Use.

  NCT07923760· University of California, San Diego· Source

• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)

  NCT07881757· Pfizer· Source

• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

  NCT07823608· Pfizer· Source

• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  NCT07369011· Eli Lilly and Company· Source

• Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea

  NCT07846865· Woolcock Institute of Medical Research· Source

• Maridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)

  2025-522699-94-00· Amgen Inc.· Source

• Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea With Complete Concentric Collapse

  NCT07898618· Brigham and Women's Hospital· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.